NVIDIA and Genentech Discuss AI Infrastructure for Drug Discovery
June 24, 2026
Panel at BIO2026 covered secure and scalable AI infrastructure for biomedical research, featuring NVIDIA and Genentech leadership. No technical specifics, model details, or product announcements were disclosed.
HOW THIS AFFECTS YOU
●
investorWorth watching as a signal of enterprise pharma commitment to NVIDIA infrastructure partnerships.
●
healthReflects growing institutional alignment between GPU vendors and major biotech on AI-driven discovery pipelines.